Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Respiratory Syncytial Virus"" wg kryterium: Temat


Tytuł :
A prospective surveillance study on the kinetics of the humoral immune response to the respiratory syncytial virus fusion protein in adults in Houston, Texas.
Autorzy :
Blunck BN; Department of Molecular Virology and Microbiology, United States.
Aideyan L; Department of Molecular Virology and Microbiology, United States.
Ye X; Department of Molecular Virology and Microbiology, United States.
Avadhanula V; Department of Molecular Virology and Microbiology, United States.
Ferlic-Stark L; Department of Molecular Virology and Microbiology, United States.
Zechiedrich L; Department of Molecular Virology and Microbiology, United States; Verna and Marrs McLean, Department of Biochemistry and Molecular Biology, United States; Department of Pharmacology and Chemical Biology, United States.
Gilbert BE; Department of Molecular Virology and Microbiology, United States.
Piedra PA; Department of Molecular Virology and Microbiology, United States; Department of Pediatrics, Baylor College of Medicine, United States. Electronic address: .
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2021 Feb 22; Vol. 39 (8), pp. 1248-1256. Date of Electronic Publication: 2021 Jan 26.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Immunity, Humoral*
Respiratory Syncytial Virus Vaccines*
Respiratory Syncytial Virus Infections/*immunology
Adult ; Antibodies, Neutralizing ; Antibodies, Viral ; Humans ; Kinetics ; Prospective Studies ; Respiratory Syncytial Virus, Human ; Texas/epidemiology ; Viral Fusion Proteins/immunology
Czasopismo naukowe
Tytuł :
Indole-3-carboxaldehyde regulates RSV-induced inflammatory response in RAW264.7 cells by moderate inhibition of the TLR7 signaling pathway.
Autorzy :
Hou X; College of Pharmacy, Nanjing University of Chinese Medicine Hanlin College, No. 6 Xueyuan Road, Taizhou, 225300, China.
Zhang X; Nanjing University of Chinese Medicine, Nanjing, 210023, China.
Bi J; Nanjing University of Chinese Medicine, Nanjing, 210023, China.
Zhu A; College of Pharmacy, Nanjing University of Chinese Medicine Hanlin College, No. 6 Xueyuan Road, Taizhou, 225300, China.
He L; College of Pharmacy, Nanjing University of Chinese Medicine Hanlin College, No. 6 Xueyuan Road, Taizhou, 225300, China. .; Nanjing University of Chinese Medicine, Nanjing, 210023, China. .
Pokaż więcej
Źródło :
Journal of natural medicines [J Nat Med] 2021 Jun; Vol. 75 (3), pp. 602-611. Date of Electronic Publication: 2021 Mar 23.
Typ publikacji :
Journal Article
MeSH Terms :
Respiratory Syncytial Virus, Human*
Signal Transduction*
Antiviral Agents/*pharmacology
Indoles/*pharmacology
Macrophages/*drug effects
Membrane Glycoproteins/*metabolism
Toll-Like Receptor 7/*metabolism
Alkaloids/pharmacology ; Animals ; Down-Regulation ; Drugs, Chinese Herbal/pharmacology ; Interferon-alpha/metabolism ; Mice ; RAW 264.7 Cells ; Respiratory Syncytial Virus Infections/immunology ; Respiratory Syncytial Virus Infections/metabolism
Czasopismo naukowe
Tytuł :
Estimating Transmission Parameters for Respiratory Syncytial Virus and Predicting the Impact of Maternal and Pediatric Vaccination.
Autorzy :
van Boven M; Centre for Infectious Disease Control, National institute for Public Health and the Environment, Bilthoven, the Netherlands.
Teirlinck AC; Centre for Infectious Disease Control, National institute for Public Health and the Environment, Bilthoven, the Netherlands.
Meijer A; Centre for Infectious Disease Control, National institute for Public Health and the Environment, Bilthoven, the Netherlands.
Hooiveld M; Nivel, Utrecht, the Netherlands.
van Dorp CH; Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, New Mexico, USA.
Reeves RM; Centre for Global Health, Usher Institute, University of Edinburgh, Edinburgh, United Kingdom.
Campbell H; Centre for Global Health, Usher Institute, University of Edinburgh, Edinburgh, United Kingdom.
van der Hoek W; Centre for Infectious Disease Control, National institute for Public Health and the Environment, Bilthoven, the Netherlands.
Pokaż więcej
Corporate Authors :
RESCEU Investigators
Źródło :
The Journal of infectious diseases [J Infect Dis] 2020 Oct 07; Vol. 222 (Suppl 7), pp. S688-S694.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Respiratory Syncytial Virus Vaccines*
Vaccination*
Respiratory Syncytial Virus Infections/*prevention & control
Respiratory Syncytial Virus Infections/*transmission
Adolescent ; Adult ; Aged ; Child ; Child, Preschool ; Hospitalization ; Humans ; Immunity ; Incidence ; Infant ; Middle Aged ; Netherlands ; Respiratory Syncytial Virus Infections/epidemiology ; Respiratory Syncytial Virus Infections/immunology ; Respiratory Syncytial Virus, Human/immunology ; Young Adult
Czasopismo naukowe
Tytuł :
Respiratory Syncytial Virus Consortium in Europe (RESCEU) Birth Cohort Study: Defining the Burden of Infant Respiratory Syncytial Virus Disease in Europe.
Autorzy :
Wildenbeest JG; Department of Paediatric Immunology and Infectious Diseases, Wilhelmina Children's Hospital/University Medical Center Utrecht, Utrecht, The Netherlands.
Zuurbier RP; Department of Paediatric Immunology and Infectious Diseases, Wilhelmina Children's Hospital/University Medical Center Utrecht, Utrecht, The Netherlands.; Spaarne Gasthuis Academy, Hoofddorp and Haarlem, The Netherlands.
Korsten K; Department of Paediatric Immunology and Infectious Diseases, Wilhelmina Children's Hospital/University Medical Center Utrecht, Utrecht, The Netherlands.
van Houten MA; Spaarne Gasthuis Academy, Hoofddorp and Haarlem, The Netherlands.
Billard MN; Department of Paediatric Immunology and Infectious Diseases, Wilhelmina Children's Hospital/University Medical Center Utrecht, Utrecht, The Netherlands.
Derksen-Lazet N; Department of Paediatric Immunology and Infectious Diseases, Wilhelmina Children's Hospital/University Medical Center Utrecht, Utrecht, The Netherlands.
Snape MD; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom.; National Institute for Health Research Oxford Biomedical Research Centre, Oxford, United Kingdom.
Drysdale SB; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom.; National Institute for Health Research Oxford Biomedical Research Centre, Oxford, United Kingdom.
Robinson H; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom.; National Institute for Health Research Oxford Biomedical Research Centre, Oxford, United Kingdom.
Pollard AJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom.; National Institute for Health Research Oxford Biomedical Research Centre, Oxford, United Kingdom.
Heikkinen T; Department of Pediatrics, University of Turku and Turku University Hospital, Turku, Finland.
Cunningham S; Centre for Inflammation Research, University of Edinburgh, Edinburgh, United Kingdom.
Leach A; GlaxoSmithKline, Rockville, Maryland, USA.
Martinón-Torres F; Translational Pediatrics and Infectious Diseases, Pediatrics Department, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain.; Genetics, Vaccines and Infections Research Group, Instituto de Investigación Sanitaria de Santiago, Santiago de Compostela, Spain.
Rodríguez-Tenreiro Sánchez C; Translational Pediatrics and Infectious Diseases, Pediatrics Department, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain.
Gómez-Carballa A; Translational Pediatrics and Infectious Diseases, Pediatrics Department, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain.; Genetics, Vaccines and Infections Research Group, Instituto de Investigación Sanitaria de Santiago, Santiago de Compostela, Spain.
Bont LJ; Department of Paediatric Immunology and Infectious Diseases, Wilhelmina Children's Hospital/University Medical Center Utrecht, Utrecht, The Netherlands.
Pokaż więcej
Corporate Authors :
RESCEU Investigators
Źródło :
The Journal of infectious diseases [J Infect Dis] 2020 Oct 07; Vol. 222 (Suppl 7), pp. S606-S612.
Typ publikacji :
Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Respiratory Syncytial Virus, Human*/isolation & purification
Hospitalization/*statistics & numerical data
Respiratory Syncytial Virus Infections/*epidemiology
Respiratory Syncytial Virus Infections/*virology
Biomarkers ; Cohort Studies ; Europe/epidemiology ; Humans ; Incidence ; Infant ; Prospective Studies ; Respiratory Syncytial Virus Infections/diagnosis ; Respiratory Syncytial Virus Infections/prevention & control ; Respiratory Syncytial Virus Vaccines ; Respiratory Tract Infections/epidemiology ; Respiratory Tract Infections/virology ; Risk Factors
Czasopismo naukowe
Tytuł :
EDP-938, a novel nucleoprotein inhibitor of respiratory syncytial virus, demonstrates potent antiviral activities in vitro and in a non-human primate model.
Autorzy :
Rhodin MHJ; Enanta Pharmaceuticals Inc., Watertown, Massachusetts, United States of America.
McAllister NV; Enanta Pharmaceuticals Inc., Watertown, Massachusetts, United States of America.
Castillo J; Enanta Pharmaceuticals Inc., Watertown, Massachusetts, United States of America.
Noton SL; Department of Microbiology, Boston University School of Medicine, Boston, Massachusetts, United States of America.
Fearns R; Department of Microbiology, Boston University School of Medicine, Boston, Massachusetts, United States of America.
Kim IJ; Enanta Pharmaceuticals Inc., Watertown, Massachusetts, United States of America.
Yu J; Enanta Pharmaceuticals Inc., Watertown, Massachusetts, United States of America.
Blaisdell TP; Enanta Pharmaceuticals Inc., Watertown, Massachusetts, United States of America.
Panarese J; Enanta Pharmaceuticals Inc., Watertown, Massachusetts, United States of America.
Shook BC; Enanta Pharmaceuticals Inc., Watertown, Massachusetts, United States of America.
Or YS; Enanta Pharmaceuticals Inc., Watertown, Massachusetts, United States of America.
Goodwin B; Enanta Pharmaceuticals Inc., Watertown, Massachusetts, United States of America.
Lin K; Enanta Pharmaceuticals Inc., Watertown, Massachusetts, United States of America.
Pokaż więcej
Źródło :
PLoS pathogens [PLoS Pathog] 2021 Mar 15; Vol. 17 (3), pp. e1009428. Date of Electronic Publication: 2021 Mar 15 (Print Publication: 2021).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Respiratory Syncytial Virus Infections*
Antiviral Agents/*pharmacology
Animals ; Cell Line ; Chlorocebus aethiops ; Disease Models, Animal ; Epithelial Cells/drug effects ; Epithelial Cells/virology ; Humans ; Respiratory Mucosa/drug effects ; Respiratory Mucosa/virology ; Respiratory Syncytial Virus, Human/drug effects
Czasopismo naukowe
Tytuł :
Pharmacological management of human respiratory syncytial virus infection.
Autorzy :
Kalergis AM; Millennium Institute on Immunology and Immunotherapy, Departamento De Genética Molecular Y Microbiología, Facultad De Ciencias Biológicas, Pontificia Universidad Católica De Chile , Santiago, Chile.; Departamento De Endocrinología, Facultad De Medicina, Pontificia Universidad Católica De Chile , Santiago, Chile.
Soto JA; Millennium Institute on Immunology and Immunotherapy, Departamento De Genética Molecular Y Microbiología, Facultad De Ciencias Biológicas, Pontificia Universidad Católica De Chile , Santiago, Chile.
Gálvez NMS; Millennium Institute on Immunology and Immunotherapy, Departamento De Genética Molecular Y Microbiología, Facultad De Ciencias Biológicas, Pontificia Universidad Católica De Chile , Santiago, Chile.
Andrade CA; Millennium Institute on Immunology and Immunotherapy, Departamento De Genética Molecular Y Microbiología, Facultad De Ciencias Biológicas, Pontificia Universidad Católica De Chile , Santiago, Chile.
Fernandez A; Millennium Institute on Immunology and Immunotherapy, Departamento De Genética Molecular Y Microbiología, Facultad De Ciencias Biológicas, Pontificia Universidad Católica De Chile , Santiago, Chile.
Bohmwald K; Millennium Institute on Immunology and Immunotherapy, Departamento De Genética Molecular Y Microbiología, Facultad De Ciencias Biológicas, Pontificia Universidad Católica De Chile , Santiago, Chile.
Bueno SM; Millennium Institute on Immunology and Immunotherapy, Departamento De Genética Molecular Y Microbiología, Facultad De Ciencias Biológicas, Pontificia Universidad Católica De Chile , Santiago, Chile.
Pokaż więcej
Źródło :
Expert opinion on pharmacotherapy [Expert Opin Pharmacother] 2020 Dec; Vol. 21 (18), pp. 2293-2303. Date of Electronic Publication: 2020 Aug 18.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Respiratory Syncytial Virus Vaccines*
Adrenal Cortex Hormones/*therapeutic use
Antiviral Agents/*therapeutic use
Bronchodilator Agents/*therapeutic use
Respiratory Syncytial Virus Infections/*drug therapy
Respiratory Syncytial Virus, Human/*drug effects
Adrenal Cortex Hormones/administration & dosage ; Adrenal Cortex Hormones/adverse effects ; Antibodies, Monoclonal, Humanized/administration & dosage ; Antibodies, Monoclonal, Humanized/adverse effects ; Antibodies, Monoclonal, Humanized/therapeutic use ; Antiviral Agents/administration & dosage ; Antiviral Agents/adverse effects ; Bronchodilator Agents/administration & dosage ; Bronchodilator Agents/adverse effects ; Humans ; Palivizumab/administration & dosage ; Palivizumab/adverse effects ; Palivizumab/therapeutic use ; Respiratory Syncytial Virus Infections/immunology ; Respiratory Syncytial Virus Infections/prevention & control ; Respiratory Syncytial Virus Infections/virology ; Respiratory Syncytial Virus, Human/immunology ; Viral Proteins/antagonists & inhibitors ; Viral Proteins/immunology
Czasopismo naukowe
Tytuł :
Integrated omics endotyping of infants with respiratory syncytial virus bronchiolitis and risk of childhood asthma.
Autorzy :
Raita Y; Department of Emergency Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. .
Pérez-Losada M; Computational Biology Institute, Department of Biostatistics and Bioinformatics, The George Washington University, Washington, DC, USA.; CIBIO-InBIO, Centro de Investigação em Biodiversidade e Recursos Genéticos, Universidade do Porto, Campus Agrário de Vairão, Vairão, Portugal.
Freishtat RJ; Center for Genetic Medicine Research, Children's National Hospital, Washington, DC, USA.; Division of Emergency Medicine, Children's National Hospital, Washington, DC, USA.; Department of Pediatrics, George Washington University School of Medicine and Health Sciences, Washington, DC, USA.
Harmon B; Center for Genetic Medicine Research, Children's National Hospital, Washington, DC, USA.
Mansbach JM; Department of Pediatrics, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
Piedra PA; Departments of Molecular Virology and Microbiology and Pediatrics, Baylor College of Medicine, Houston, TX, USA.
Zhu Z; Department of Emergency Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Camargo CA; Department of Emergency Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Hasegawa K; Department of Emergency Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Pokaż więcej
Źródło :
Nature communications [Nat Commun] 2021 Jun 14; Vol. 12 (1), pp. 3601. Date of Electronic Publication: 2021 Jun 14.
Typ publikacji :
Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Asthma/*complications
Asthma/*virology
Bronchiolitis, Viral/*complications
Bronchiolitis, Viral/*virology
Respiratory Syncytial Virus Infections/*complications
Respiratory Syncytial Virus Infections/*virology
Asthma/epidemiology ; Female ; Gene Expression ; Genetic Predisposition to Disease ; Hospitalization ; Humans ; Infant ; Male ; Metabolome ; Microbiota ; Prospective Studies ; Respiratory Syncytial Virus Infections/epidemiology ; Respiratory Syncytial Virus, Human/genetics ; Respiratory System ; Rhinovirus ; Risk Factors ; Transcriptome ; United States/epidemiology
Czasopismo naukowe
Tytuł :
Balancing precision versus cohort transcriptomic analysis of acute and recovery phase of viral bronchiolitis.
Autorzy :
Gupta R; Department of Pediatrics and Human Development, College of Human Medicine, Michigan State University, Grand Rapids, Michigan.; Department of Pharmacology and Toxicology, Michigan State University, East Lansing, Michigan.
Leimanis ML; Department of Pediatrics and Human Development, College of Human Medicine, Michigan State University, Grand Rapids, Michigan.; Pediatric Intensive Care Unit, Helen DeVos Children's Hospital, Grand Rapids, Michigan.
Adams M; Genomics Core Facility, Van Andel Institute, Grand Rapids, Michigan.
Bachmann AS; Department of Pediatrics and Human Development, College of Human Medicine, Michigan State University, Grand Rapids, Michigan.
Uhl KL; Department of Pediatrics and Human Development, College of Human Medicine, Michigan State University, Grand Rapids, Michigan.; Department of Pharmacology and Toxicology, Michigan State University, East Lansing, Michigan.
Bupp CP; Spectrum Health Medical Genetics, Grand Rapids, Michigan.
Hartog NL; Allergy & Immunology, Spectrum Health, Grand Rapids, Michigan.
Kort EJ; Department of Pediatrics and Human Development, College of Human Medicine, Michigan State University, Grand Rapids, Michigan.; DeVos Cardiovascular Research Program, Spectrum Health and Van Andel Institute, Grand Rapids, Michigan.
Olivero R; Department of Pediatrics and Human Development, College of Human Medicine, Michigan State University, Grand Rapids, Michigan.; Infectious Disease, Helen DeVos Children's Hospital, Grand Rapids, Michigan.
Comstock SS; Department of Food Science and Human Nutrition, Michigan State University, East Lansing, Michigan.
Sanfilippo DJ; Department of Pediatrics and Human Development, College of Human Medicine, Michigan State University, Grand Rapids, Michigan.; Pediatric Intensive Care Unit, Helen DeVos Children's Hospital, Grand Rapids, Michigan.
Lunt SY; Biochemistry and Molecular Biology, Michigan State University, East Lansing, Michigan.; Chemical Engineering and Materials Science, Michigan State University, East Lansing, Michigan.
Prokop JW; Department of Pediatrics and Human Development, College of Human Medicine, Michigan State University, Grand Rapids, Michigan.; Department of Pharmacology and Toxicology, Michigan State University, East Lansing, Michigan.
Rajasekaran S; Department of Pediatrics and Human Development, College of Human Medicine, Michigan State University, Grand Rapids, Michigan.; Pediatric Intensive Care Unit, Helen DeVos Children's Hospital, Grand Rapids, Michigan.; Office of Research, Spectrum Health, Grand Rapids, Michigan.
Pokaż więcej
Źródło :
American journal of physiology. Lung cellular and molecular physiology [Am J Physiol Lung Cell Mol Physiol] 2021 Jun 01; Vol. 320 (6), pp. L1147-L1157. Date of Electronic Publication: 2021 Apr 14.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Bronchiolitis, Viral/*virology
Minor Histocompatibility Antigens/*pharmacology
Respiratory Syncytial Virus Infections/*drug therapy
Transcriptome/*drug effects
Bronchiolitis, Viral/blood ; Humans ; Respiratory Syncytial Virus Infections/immunology ; Respiratory Syncytial Virus, Human/drug effects ; Respiratory Syncytial Virus, Human/pathogenicity ; Severity of Illness Index ; Transcriptome/immunology ; Virus Diseases/drug therapy ; Virus Diseases/virology
Czasopismo naukowe
Tytuł :
The journey to a respiratory syncytial virus vaccine.
Autorzy :
Mejias A; Center for Vaccines and Immunity, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio; Division of Pediatric Infectious Diseases, Nationwide Children's Hospital, The Ohio State University, Columbus, Ohio; Departamento de Farmacologia y Pediatria, Facultad de Medicina, Universidad de Malaga, Malaga, Spain. Electronic address: .
Rodríguez-Fernández R; Department of Pediatrics, Hospital Infantil Gregorio Marañón, Madrid, Spain; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
Oliva S; Division of Pediatric Emergency Medicine and Critical Care, Hospital Regional Universitario de Malaga, Malaga, Spain; Departamento de Farmacologia y Pediatria, Facultad de Medicina, Universidad de Malaga, Malaga, Spain.
Peeples ME; Center for Vaccines and Immunity, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio.
Ramilo O; Center for Vaccines and Immunity, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio; Division of Pediatric Infectious Diseases, Nationwide Children's Hospital, The Ohio State University, Columbus, Ohio.
Pokaż więcej
Źródło :
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology [Ann Allergy Asthma Immunol] 2020 Jul; Vol. 125 (1), pp. 36-46. Date of Electronic Publication: 2020 Mar 23.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Respiratory Syncytial Virus Vaccines*
Respiratory Syncytial Virus Infections/*prevention & control
Female ; Humans ; Male ; Respiratory Syncytial Virus, Human/immunology
Czasopismo naukowe
Tytuł :
Impact of Respiratory Syncytial Virus Infection on Host Functions: Implications for Antiviral Strategies.
Autorzy :
Hu M; Department of Biochemistry and Molecular Biology, University of Melbourne, Melbourne, Victoria, Australia; and Department of Biochemistry and Molecular Biology, Monash University, Melbourne, Victoria, Australia.
Bogoyevitch MA; Department of Biochemistry and Molecular Biology, University of Melbourne, Melbourne, Victoria, Australia; and Department of Biochemistry and Molecular Biology, Monash University, Melbourne, Victoria, Australia.
Jans DA; Department of Biochemistry and Molecular Biology, University of Melbourne, Melbourne, Victoria, Australia; and Department of Biochemistry and Molecular Biology, Monash University, Melbourne, Victoria, Australia.
Pokaż więcej
Źródło :
Physiological reviews [Physiol Rev] 2020 Oct 01; Vol. 100 (4), pp. 1527-1594. Date of Electronic Publication: 2020 Mar 26.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Respiratory Syncytial Virus, Human*
Antiviral Agents/*pharmacology
Respiratory Syncytial Virus Infections/*prevention & control
Respiratory Syncytial Virus Infections/*virology
Viral Vaccines/*immunology
Humans ; Respiratory Syncytial Virus Infections/drug therapy ; Respiratory Syncytial Virus Infections/immunology
Czasopismo naukowe
Tytuł :
A codon-pair deoptimized live-attenuated vaccine against respiratory syncytial virus is immunogenic and efficacious in non-human primates.
Autorzy :
Mueller S; Codagenix, Inc., Farmingdale, NY, United States. Electronic address: .
Stauft CB; Codagenix, Inc., Farmingdale, NY, United States. Electronic address: .
Kalkeri R; Southern Research, Inc., Frederick, MD, United States. Electronic address: .
Koidei F; Southern Research, Inc., Frederick, MD, United States. Electronic address: .
Kushnir A; Codagenix, Inc., Farmingdale, NY, United States. Electronic address: .
Tasker S; Codagenix, Inc., Farmingdale, NY, United States. Electronic address: .
Coleman JR; Codagenix, Inc., Farmingdale, NY, United States. Electronic address: .
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2020 Mar 23; Vol. 38 (14), pp. 2943-2948. Date of Electronic Publication: 2020 Feb 24.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Codon*
Respiratory Syncytial Virus Infections*/prevention & control
Respiratory Syncytial Virus Vaccines/*immunology
Animals ; Antibodies, Viral/blood ; Chlorocebus aethiops ; Computer-Aided Design ; Immunity, Cellular ; Immunity, Humoral ; Respiratory Syncytial Virus Vaccines/genetics ; Respiratory Syncytial Virus, Human ; Vaccines, Attenuated/genetics ; Vaccines, Attenuated/immunology ; Vero Cells
Czasopismo naukowe
Tytuł :
Respiratory Syncytial Virus-Associated Hospital Admissions in Children Younger Than 5 Years in 7 European Countries Using Routinely Collected Datasets.
Autorzy :
Reeves RM; Centre for Global Health, University of Edinburgh, Edinburgh, United Kingdom.
van Wijhe M; Department of Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.
Tong S; Sanofi, Chilly-Mazarin, France.
Lehtonen T; Finnish Institute for Health and Welfare, Helsinki, Finland.; Turku University Hospital, Turku, Finland.
Stona L; Fondazione Penta, Padova, Italy.
Teirlinck AC; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
Fernandez LV; Department of Infectious Diseases, Epidemiology, and Modelling, Norwegian Institute of Public Health, Oslo, Norway.
Li Y; Centre for Global Health, University of Edinburgh, Edinburgh, United Kingdom.
Giaquinto C; Fondazione Penta, Padova, Italy.
Fischer TK; Department of Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.; Department of Clinical Research, Nordsjælland Hospital Hilleroed and University of Southern Denmark, Odense, Denmark.
Demont C; Global Vaccine Epidemiology and Modelling Department, Sanofi Pasteur, Lyon, France.
Heikkinen T; Department of Pediatrics, University of Turku and Turku University Hospital, Turku, Finland.
Speltra I; Fondazione Penta, Padova, Italy.
van Boven M; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
Bøås H; Department of Infectious Diseases, Epidemiology, and Modelling, Norwegian Institute of Public Health, Oslo, Norway.
Campbell H; Centre for Global Health, University of Edinburgh, Edinburgh, United Kingdom.
Pokaż więcej
Corporate Authors :
RESCEU Investigators
Źródło :
The Journal of infectious diseases [J Infect Dis] 2020 Oct 07; Vol. 222 (Suppl 7), pp. S599-S605.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Respiratory Syncytial Virus, Human*
Hospitalization/*statistics & numerical data
Respiratory Syncytial Virus Infections/*epidemiology
Respiratory Syncytial Virus Infections/*virology
Child, Preschool ; Europe/epidemiology ; Female ; Hospitals ; Humans ; Infant ; Infant, Newborn ; Male ; Respiratory Syncytial Virus Infections/prevention & control ; Respiratory Tract Infections/epidemiology ; Respiratory Tract Infections/prevention & control ; Vaccination
Czasopismo naukowe
Tytuł :
Acute Lower Respiratory Infections Associated With Respiratory Syncytial Virus in Children With Underlying Congenital Heart Disease: Systematic Review and Meta-analysis.
Autorzy :
Chaw PS; Institute for Medical Epidemiology, Biometry, and Informatics, Medical Faculty, Martin Luther University of Halle-Wittenberg, Halle, Germany.
Wong SWL; Centre for Global Health Research, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh Medical School, Edinburgh, United Kingdom.
Cunningham S; Department of Child Life and Health, University of Edinburgh, Edinburgh, United Kingdom.
Campbell H; Centre for Global Health Research, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh Medical School, Edinburgh, United Kingdom.
Mikolajczyk R; Institute for Medical Epidemiology, Biometry, and Informatics, Medical Faculty, Martin Luther University of Halle-Wittenberg, Halle, Germany.
Nair H; Centre for Global Health Research, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh Medical School, Edinburgh, United Kingdom.; ReSViNET Foundation, Zeist, the Netherlands.
Pokaż więcej
Corporate Authors :
RESCEU Investigators
Źródło :
The Journal of infectious diseases [J Infect Dis] 2020 Oct 07; Vol. 222 (Suppl 7), pp. S613-S619.
Typ publikacji :
Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Systematic Review
MeSH Terms :
Respiratory Syncytial Virus, Human*
Heart Defects, Congenital/*complications
Respiratory Syncytial Virus Infections/*complications
Respiratory Tract Infections/*complications
Databases, Factual ; Heart Defects, Congenital/mortality ; Heart Defects, Congenital/therapy ; Hospitalization/statistics & numerical data ; Humans ; Incidence ; Infant ; Infant, Newborn ; Odds Ratio ; Oxygen Inhalation Therapy ; Respiration, Artificial ; Respiratory Syncytial Virus Infections/mortality ; Respiratory Syncytial Virus Infections/therapy ; Respiratory Tract Infections/mortality ; Respiratory Tract Infections/therapy ; Respiratory Tract Infections/virology ; Risk Factors
Czasopismo naukowe
Tytuł :
Burden of respiratory syncytial virus hospitalisation among infants born at 32-35 weeks' gestational age in the Northern Hemisphere: pooled analysis of seven studies.
Autorzy :
Lanari M; Pediatric Emergency Unit, Department of Medical and Surgical Sciences, S. Orsola University Hospital, Bologna, Italy.
Anderson EJ; Departments of Pediatrics and Medicine, Emory University School of Medicine, Atlanta, GA, USA.
Sheridan-Pereira M; Department of Paediatrics, Trinity College and Coombe Women and Infants University Hospital, Dublin, Ireland.
Carbonell-Estrany X; Neonatology Service, Hospital Clinic, Institut d'Investigacions Biomediques August Pi Suñer (IDIBAPS), Barcelona, Spain.
Paes B; Department of Pediatrics (Neonatal Division), McMaster University, Hamilton, Ontario, Canada.
Rodgers-Gray BS; Strategen Limited, Winchester, UK.
Fullarton JR; Strategen Limited, Winchester, UK.
Grubb E; Health Economics and Outcomes Research, AbbVie Inc, North Chicago, Illinois, USA.
Blanken M; Division of Pediatric Immunology and Infectious Diseases, University Medical Center Utrecht, Utrecht, The Netherlands.
Pokaż więcej
Źródło :
Epidemiology and infection [Epidemiol Infect] 2020 Aug 17; Vol. 148, pp. e170. Date of Electronic Publication: 2020 Aug 17.
Typ publikacji :
Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Systematic Review
MeSH Terms :
Respiratory Syncytial Virus, Human*
Hospitalization/*statistics & numerical data
Respiratory Syncytial Virus Infections/*pathology
Antiviral Agents/therapeutic use ; Cohort Studies ; Gestational Age ; Humans ; Infant ; Length of Stay ; Multicenter Studies as Topic ; Observational Studies as Topic ; Respiratory Syncytial Virus Infections/epidemiology ; Respiratory Syncytial Virus Infections/therapy
Czasopismo naukowe
Tytuł :
Supplementing a Saccharomyces cerevisiae fermentation product modulates innate immune function and ameliorates bovine respiratory syncytial virus infection in neonatal calves.
Autorzy :
Mahmoud AHA; Department of Veterinary Microbiology and Preventive Medicine, Iowa State University, Ames, IA.; Agricultural Research Center, Animal Health Research Institute, Giza, Egypt.
Slate JR; Department of Veterinary Microbiology and Preventive Medicine, Iowa State University, Ames, IA.
Hong S; Department of Veterinary Microbiology and Preventive Medicine, Iowa State University, Ames, IA.
Yoon I; Diamond V Mills Inc., Cedar Rapids, IA.
McGill JL; Department of Veterinary Microbiology and Preventive Medicine, Iowa State University, Ames, IA.
Pokaż więcej
Źródło :
Journal of animal science [J Anim Sci] 2020 Aug 01; Vol. 98 (8).
Typ publikacji :
Journal Article; Randomized Controlled Trial, Veterinary
MeSH Terms :
Respiratory Syncytial Virus, Bovine*/immunology
Cattle Diseases/*virology
Immunity, Innate/*drug effects
Respiratory Syncytial Virus Infections/*veterinary
Saccharomyces cerevisiae/*metabolism
Animals ; Body Weight ; Cattle ; Cattle Diseases/drug therapy ; Diet/veterinary ; Fermentation ; Milk ; Respiratory Syncytial Virus Infections/drug therapy ; Respiratory Syncytial Virus Infections/immunology
Czasopismo naukowe
Tytuł :
Live-attenuated Vaccines Prevent Respiratory Syncytial Virus-associated Illness in Young Children.
Autorzy :
Karron RA; Department of International Health, Center for Immunization Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Atwell JE; Department of International Health, Center for Immunization Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
McFarland EJ; Department of Pediatrics, University of Colorado Anschutz Medical Campus and Children's Hospital Colorado, Aurora, Colorado.
Cunningham CK; Department of Pediatrics, Duke University Medical Center, Durham, North Carolina.
Muresan P; Center for Biostatistics in AIDS Research, Harvard School of Public Health/Frontier Science Foundation, Boston, Massachusetts.
Perlowski C; FHI 360, Durham, North Carolina.
Libous J; FHI 360, Durham, North Carolina.
Spector SA; Department of Pediatrics and Rady Children's Hospital San Diego, University of California San Diego, San Diego, California.
Yogev R; Northwestern Feinberg School of Medicine, Chicago, Illinois.
Aziz M; Section of Infectious Disease, Rush University Medical Center, Chicago, Illinois; and.
Woods S; Department of International Health, Center for Immunization Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Wanionek K; Department of International Health, Center for Immunization Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Collins PL; RNA Viruses Section, Laboratory of Infectious Diseases, National Institute of Allergy, Immunology, and Infectious Diseases, NIH, Bethesda, Maryland.
Buchholz UJ; RNA Viruses Section, Laboratory of Infectious Diseases, National Institute of Allergy, Immunology, and Infectious Diseases, NIH, Bethesda, Maryland.
Pokaż więcej
Źródło :
American journal of respiratory and critical care medicine [Am J Respir Crit Care Med] 2021 Mar 01; Vol. 203 (5), pp. 594-603.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural
MeSH Terms :
Respiratory Syncytial Virus Infections/*prevention & control
Respiratory Syncytial Virus Vaccines/*therapeutic use
Antibodies, Neutralizing/immunology ; Antibodies, Viral/immunology ; Clinical Trials, Phase I as Topic ; Female ; Humans ; Immunogenicity, Vaccine/immunology ; Immunologic Memory/immunology ; Infant ; Male ; Randomized Controlled Trials as Topic ; Respiratory Syncytial Virus Infections/physiopathology ; Respiratory Syncytial Virus, Human/immunology ; Treatment Outcome ; Vaccines, Attenuated/therapeutic use
Czasopismo naukowe
Tytuł :
Herd level estimation of probability of disease freedom applied on the Norwegian control program for bovine respiratory syncytial virus and bovine coronavirus.
Autorzy :
Toftaker I; Department of Production Animal Clinical Sciences, Norwegian University of Life Sciences, P.O. Box 8146 Dep, Oslo, Norway. Electronic address: .
Ågren E; Department of Disease Control and Epidemiology, National Veterinary Institute, Uppsala, Sweden.
Stokstad M; Department of Production Animal Clinical Sciences, Norwegian University of Life Sciences, P.O. Box 8146 Dep, Oslo, Norway.
Nødtvedt A; Department of Production Animal Clinical Sciences, Norwegian University of Life Sciences, P.O. Box 8146 Dep, Oslo, Norway.
Frössling J; Department of Disease Control and Epidemiology, National Veterinary Institute, Uppsala, Sweden; Department of Animal Environment and Health, Swedish University of Agricultural Sciences, Skara, Sweden.
Pokaż więcej
Źródło :
Preventive veterinary medicine [Prev Vet Med] 2020 Aug; Vol. 181, pp. 104494. Date of Electronic Publication: 2018 Jul 21.
Typ publikacji :
Journal Article
MeSH Terms :
Coronavirus, Bovine*
Respiratory Syncytial Virus, Bovine*
Cattle Diseases/*prevention & control
Coronavirus Infections/*veterinary
Respiratory Syncytial Virus Infections/*veterinary
Animals ; Antibodies, Viral/immunology ; Cattle/virology ; Cattle Diseases/epidemiology ; Cattle Diseases/virology ; Coronavirus Infections/epidemiology ; Coronavirus Infections/prevention & control ; Female ; Infection Control/methods ; Milk/immunology ; Norway/epidemiology ; Probability ; Respiratory Syncytial Virus Infections/epidemiology ; Respiratory Syncytial Virus Infections/prevention & control
Czasopismo naukowe
Tytuł :
Seasonal shift in epidemics of respiratory syncytial virus infection in Japan.
Autorzy :
Miyama T; Department of Public Health, Osaka Institute of Public Health, Osaka, Japan.
Iritani N; Department of Public Health, Osaka Institute of Public Health, Osaka, Japan.
Nishio T; Department of Public Health, Osaka Institute of Public Health, Osaka, Japan.
Ukai T; Department of Public Health, Osaka Institute of Public Health, Osaka, Japan.
Satsuki Y; Department of Public Health, Osaka Institute of Public Health, Osaka, Japan.
Miyata H; Department of Social Medicine, Osaka University Graduate School of Medicine, Suita, Japan.
Shintani A; Department of Medical Statistics, Osaka City University Graduate School of Medicine, Osaka, Japan.
Hiroi S; Department of Microbiology, Osaka Institute of Public Health, Osaka, Japan.
Motomura K; Department of Microbiology, Osaka Institute of Public Health, Osaka, Japan.
Kobayashi K; Department of Public Health, Osaka Institute of Public Health, Osaka, Japan.
Pokaż więcej
Źródło :
Epidemiology and infection [Epidemiol Infect] 2021 Feb 11; Vol. 149, pp. e55. Date of Electronic Publication: 2021 Feb 11.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Epidemics/*statistics & numerical data
Respiratory Syncytial Virus Infections/*epidemiology
Humans ; Japan/epidemiology ; Respiratory Syncytial Virus Infections/virology ; Respiratory Syncytial Virus, Human ; Seasons ; Time Factors
Czasopismo naukowe
Tytuł :
Clinical impact of respiratory syncytial virus infection on children hospitalized for pertussis.
Autorzy :
Zhang R; Department of Infectious Diseases, Shenzhen Children's Hospital, Shenzhen, China.
Deng J; Department of Infectious Diseases, Shenzhen Children's Hospital, Shenzhen, China. .
Pokaż więcej
Źródło :
BMC infectious diseases [BMC Infect Dis] 2021 Feb 09; Vol. 21 (1), pp. 161. Date of Electronic Publication: 2021 Feb 09.
Typ publikacji :
Journal Article
MeSH Terms :
Respiratory Syncytial Virus Infections/*diagnosis
Whooping Cough/*diagnosis
Anti-Bacterial Agents/therapeutic use ; Bordetella pertussis/genetics ; Bordetella pertussis/isolation & purification ; Coinfection/diagnosis ; Female ; Hospitalization ; Humans ; Infant ; Length of Stay ; Logistic Models ; Male ; Patient Readmission ; RNA, Viral/metabolism ; Real-Time Polymerase Chain Reaction ; Respiratory Syncytial Virus Infections/complications ; Respiratory Syncytial Virus Infections/virology ; Respiratory Syncytial Virus, Human/genetics ; Respiratory Syncytial Virus, Human/isolation & purification ; Retrospective Studies ; Whooping Cough/complications ; Whooping Cough/drug therapy ; Whooping Cough/microbiology
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies